In 2023, Catherine Bollard earned $480.50K in total compensation at Cabaletta Bio, Inc., primarily from $480.50K salary. Most recently acquired 1,000 shares in Oct 2022. Currently holds stock worth $2.55K. Led Cabaletta Bio, Inc. as CEO for 2 years.
Compensation History
Annual executive compensation data for Catherine Bollard, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$480.50K
Salary
$480.50K
Bonus
$0.00
Other
$0.00
Salary
$480.50KBoard Justification
The compensation philosophy is to align executive compensation with company performance and market benchmarks.
Bonus
$0.00Board Justification
No bonus was awarded for the year 2023.
Other Compensation
$0.00Board Justification
No other compensation was reported for 2023.
Restricted Stock
Board Justification
No stock awards vested in 2023.
Performance Metrics
Performance metrics for 2023 were based on individual and company performance, with a target bonus rate of 40% of base salary.
Catherine Bollard
Ex-CEO of Cabaletta Bio, Inc.
Education
MD from Stanford University
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
March 10, 1973 - 52 years ago
CEO of Cabaletta Bio, Inc. for
2 years 0 months (Jun 2021 - Jul 2023)
Previous Experience
Director of Research at ABC Pharmaceuticals
Other Cabaletta Bio, Inc. CEOs
Holdings
Track Catherine Bollard's stock holdings and portfolio value over time.
Insider Trading
Catherine Bollard's recent stock transactions, purchases, and sales filed with the SEC.
$993.50
CABA at $0.99/share
Oct 18, 2022
Purchase
Rivals
Compare Catherine Bollard with competitor CEOs and industry peers.